Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3597 studies found for:    "Carcinoma, Non-Small-Cell Lung"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-3512676 + Paclitaxel + Carboplatin;   Drug: Paclitaxel + Carboplatin
2 Terminated
Has Results
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Part 1: Sym004 6 mg/kg + Cisplatin/Gemcitabine;   Drug: Part 1: Sym004 6 mg/kg + Cisplatin/Pemetrexed;   Drug: Part 1: Sym004 6 mg/kg + Carboplatin/Paclitaxel;   Drug: Part 1: Sym004 6/12 mg/kg + Carboplatin/Paclitaxel
3 Recruiting Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Oshadi D and Oshadi R;   Drug: Docetaxel
4 Completed ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: ZD6474;   Drug: Paclitaxel;   Drug: Carboplatin
5 Active, not recruiting Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non Small Cell Lung
Interventions: Drug: Docetaxel;   Drug: Suramin
6 Completed
Has Results
Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gefitinib retreatment
7 Suspended Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: JNJ-64041757 (Cohort 1A and 1B);   Biological: JNJ-64041757 (Cohort 2A and 2B)
8 Terminated Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: pemetrexed;   Drug: pemetrexed + PF-3512676
9 Active, not recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
10 Completed
Has Results
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Intervention: Drug: Tarceva (Erlotinib)
11 Completed Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: neoadjuvant erlotinib therapy;   Drug: neoadjuvant gemcitabine/carboplatin therapy
12 Completed Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin, Ifosfamide, Gemcitabine;   Drug: Ifosfamide, Gemcitabine;   Drug: Cisplatin, docetaxel
13 Completed Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: TLK286;   Drug: carboplatin;   Drug: paclitaxel
14 Active, not recruiting Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ruxolitinib;   Drug: Placebo;   Drug: Pemetrexed;   Drug: Cisplatin
15 Terminated
Has Results
A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Vorinostat;   Drug: erlotinib
16 Completed A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: LY900003
17 Completed Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Sunitinib
18 Terminated Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Tecemotide;   Drug: Placebo;   Drug: Cyclophosphamide (CPA);   Drug: Saline (sodium chloride)
19 Terminated
Has Results
Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Oxaliplatin + Docetaxel
20 Completed Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: SGN-15;   Drug: Docetaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.